TradeFlare's AI research teams analysed KLRA on 3 market nights between April 21, 2026 and April 27, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| April 27, 2026 | BUY | $22.47 | $25.84 / $19.11 | +6.7% | -8.2% | The insider buying is a positive signal, but the bearish technicals and high risk profile require further confirmation before initiating a position. |
| April 23, 2026 | BUY | $24.30 | — / — | -0.3% | -15.9% | Successful clinical trial results for drug candidates. |
| April 21, 2026 | BUY | $24.61 | $27.50 / $23.70 | -5.5% | -22.2% | Insider buying is a longer-term signal, but the lack of bullish signals and moderate risk score warrant a shorter timeframe. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.